SIGNIFICANCE OF ANEMIA IN PATIENTS WITH CML AT DIAGNOSIS AND DURING THE TREATMENT WITH IMATINIB OUTSIDE THE CLINICAL TRIALS: CAMELIA REGISTRY EXPERIENCE

被引：0
|
作者：
Faber, E. [1 ,2 ]
Muzik, J. [3 ]
Janousova, E. [3 ]
Dufkova, T. [3 ]
Jindra, P. [4 ]
Cmunt, E. [5 ]
Sninska, Z. [6 ]
Demitrovicova, L. [7 ]
Mikuskova, E. [7 ]
Chudej, J. [8 ]
Markuljak, I. [9 ]
Palasthy, S. [10 ]
Stecova, N. [11 ]
Tothova, E. [11 ]
Dusek, L. [3 ]
Indrak, K. [1 ,2 ]
机构：
[1] Fac Hosp Olomouc, Dept Hematooncol, Olomouc, Czech Republic
[2] Palacky Univ, Fac Med & Dent, CR-77147 Olomouc, Czech Republic
[3] Masaryk Univ, Fac Med, Inst Biostat & Anal, Brno, Czech Republic
[4] Univ Hosp, Dept Hematooncol, Plzen, Czech Republic
[5] Univ Hosp, Internal Dept 1, Prague, Czech Republic
[6] Univ Hosp, Inst Hematol & Blood Transfus, Bratislava, Slovakia
[7] Natl Canc Inst, Dept Hematooncol, Bratislava, Slovakia
[8] Univ Hosp, Dept Clin Hematol, Martin, Slovakia
[9] Univ Hosp, Dept Clin Hematol, Banska Bystrica, Slovakia
[10] Univ Hosp, Dept Clin Hematol, Presov, Slovakia
[11] Univ Hosp, Dept Clin Hematol, Kosice, Slovakia
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1116
引用
收藏
页码：445 / 445
页数：1
相关论文
共 50 条
  • [1] Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (ST1571)
    Agis, H.
    Sperr, W. R.
    Herndlhofer, S.
    Semper, H.
    Pirc-Danoewinata, H.
    Haas, O. A.
    Mannhalter, C.
    Esterbauer, H.
    Geissler, K.
    Sillaber, C.
    Jaeger, U.
    Valent, P.
    ANNALS OF ONCOLOGY, 2007, 18 (11) : 1834 - 1841
  • [2] Therapy in Patients with Chronic Myeloid Leukemia Outside of Clinical Trials: Results of the German CML-Registry (CML-VI)
    Kohlbrenner, Katharina
    Galuschek, Norbert
    Fabarius, Alice
    Reiser, Marcel
    Fenchel, Klaus
    Esseling, Eva
    Goehler, Thomas
    Geer, Thomas
    Depenbusch, Reinhard
    Azeh, Ivo Talah
    Engel, Erik
    Hansen, Richard
    Lindemann, Hans-Walter
    Anhuf, Juergen
    Jehner, Paul
    Abu-Samra, Maisun
    Ritter, Markus
    Gattermann, Norbert
    Pelz, Henning
    Fuxius, Stefan
    Oswald, Burkhard
    Baerlocher, Gabriela M.
    Brummendorf, Tim H. H.
    Heim, Dominik
    le Coutre, Philipp
    Burchert, Andreas
    Niederwieser, Dietger
    Tesch, Hans
    Hofmann, Wolf-Karsten
    Hochhaus, Andreas
    Hehlmann, Ruediger
    Saussele, Susanne
    BLOOD, 2022, 140
  • [3] Treatment and resistance to imatinib in CML patients: Experience of a Portuguese center
    Castro, I.
    Santo, A. Espirito
    Cameiro, A.
    Silva, M. J.
    Fernandes, A.
    Cancela, J.
    Principe, F.
    Ferreira, F.
    Lemos, R.
    Andrade, J.
    Costa, A.
    Trigo, F.
    Moreira, I.
    Costa, T.
    Silva, F.
    Guimaraes, J. E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 248 - 248
  • [4] Random aneuploidy in CML patients at diagnosis and under imatinib treatment
    Amiel, A.
    Yukla, M.
    Gaber, E.
    Leopold, L.
    Josef, G.
    Fejgin, M.
    Lishner, M.
    CANCER GENETICS AND CYTOGENETICS, 2006, 168 (02) : 120 - 123
  • [5] A Good Adherence to ELN 09 Recommendations in Chronic Myeloid Leukemia (CML) Treatment with Imatinib, Is Associated with Better Outcomes in Patients Treated Outside Clinical Trials
    Felipe Casado, Luis
    Maestro, Begona
    Valentin Garcia-Gutierrez, J.
    Helene Dumas, Marie
    Massague, Isabel
    Giraldo, Pilar
    Perez-Encinas, Manuel
    de Paz, Raquel
    Martinez-Lopez, Joaqun
    Bautista, Guiomar
    Osorio, Santiago
    Jose Requena, Maria
    Palomera, Luis
    Jesus Penarrubia, Maria
    Calle, Carmen
    Angel Hernandez-Rivas, Jose
    Burgaleta, Carmen
    Andrade, Marcio M., Sr.
    Garcia-Ormena, Nuria
    Luis Steegmann, Juan
    BLOOD, 2012, 120 (21)
  • [6] CML patients show sperm alterations at diagnosis that are not improved with imatinib treatment
    Nicolini, Franck-Emmanuel
    Alcazer, Vincent
    Huguet, Francoise
    Cony-Makhoul, Pascale
    Heiblig, Mael
    Fort, Marie-Pierre
    Morisset, Stephan
    Guerci-Bresler, Agnes
    Soula, Volcy
    Sobh, Mohamad
    d'Estaing, Sandrine Giscard
    Daudin, Myriam
    Etienne, Gabriel
    LEUKEMIA RESEARCH, 2016, 48 : 80 - 83
  • [7] High age and high frequency of treatment switch in CML patients outside of clinical trials: interim results of the German CML VI trial
    Kohlbrenner, K.
    Arnecke, L.
    Fabarius, A.
    Bieber, R.
    Voskanyan, A.
    Reiser, M.
    Fenchel, K.
    Schmidt, E.
    Goehler, T.
    Kuehn, R. B.
    Depenbusch, R.
    Azeh, I.
    Kleeberg, U. R.
    Hansen, R.
    Haenel, M.
    Anhuf, J.
    Jehner, P.
    Baerlocher, G. M.
    Bruemmendorf, T. H.
    Ehninger, G.
    Hasford, J.
    Heim, D.
    Hossfeld, D. K.
    Kolb, H. -J.
    Krause, S. W.
    le Coutre, P.
    Nerl, C.
    Neubauer, A.
    Niederwieser, D.
    Tesch, H.
    Hochhaus, A.
    Hehlmann, R.
    Saussele, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 145 - 145
  • [8] Imatinib (Glivec®) in the treatment of patients with CML in accelerated phase -: Czech experience.
    Faber, E
    Hlusf, A
    Indrák, K
    Jarosová, M
    Holzerová, M
    Zapletalová, J
    Klamová, H
    Vítek, A
    Voglová, J
    Zák, P
    Brychtová, Y
    Cieslar, P
    Haber, J
    Slaby, J
    Sumná, E
    Vozobulová, V
    Kuncar, J
    Sisková, M
    Cmunt, E
    Heinzová, V
    Blazek, B
    BLOOD, 2002, 100 (11) : 319B - 319B
  • [9] EFFICACY AND SAFETY EVALUATION OF NILOTINIB AND DASATINIB (2G-TKI) ON FIRST LINE TREATMENT IN 73 PATIENTS WITH CML-CP OUTSIDE OF CLINICAL TRIALS. ANDALUSIAN CML REGISTRY (RALMC)
    Puerta, J. M.
    Jimenez Velasco, A.
    Garcia, M. J.
    Molina, J. R.
    Ruiz, C.
    Ferrer, C.
    Duran, M. S.
    Simon, I.
    Clavero, E.
    Avellaneda, M. C.
    Rosell, A.
    Ballesteros, I.
    Ramirez, S.
    Portero, M. A.
    Ramirez, M. J.
    Fernandez, M.
    Jimenez, M.
    Fe, R.
    Mulero, N.
    Lopez, P.
    HAEMATOLOGICA, 2016, 101 : 736 - 736
  • [10] The Significance of PET/CT in the Initial Staging of Hodgkin Lymphoma: Experience Outside Clinical Trials
    Angelopoulou, Maria K.
    Mosa, Eftychia
    Pangalis, Gerassimos A.
    Rondogianni, Phoivi
    Chatziioannou, Sofia
    Prassopoulos, Vassilios
    Moschogianni, Maria
    Tsirkinidis, Pantelis
    Asimakopoulos, John V.
    Konstantinou, Iliana
    Tsourouflis, Gerasimos
    Sachanas, Sotirios
    Yiakoumis, Xanthi
    Boutsikas, George
    Arapaki, Maria
    Gainaru, Gabriella
    Kyrtsonis, Marie-Christine
    Siakantaris, Marina P.
    Datseris, Ioannis
    Panayiotidis, Panagiotis
    Konstantopoulos, Kostas
    Vassilakopoulos, Theodoros P.
    ANTICANCER RESEARCH, 2017, 37 (10) : 5727 - 5736
12345